On this page
DKC1
dyskerin pseudouridine synthase 1
The DKC1 gene provides instructions for producing dyskerin, a protein vital for maintaining telomeres and producing ribosomal RNA, with variants linked to inherited conditions like X-linked dyskeratosis congenita. The DKC1 gene encodes the dyskerin protein, which plays a critical role in cellular function by stabilising telomeres, the protective caps at chromosome ends, and facilitating ribosomal RNA production.
DKC1 is located on the long (q) arm of chromosome X, at band Xq28. Arm ratio per GRCh38 - banding schematic.
Explore chromosome X in the library →Available at Jeen Health
Clinical tests that include this
Overview
The DKC1 gene, also known as dyskerin pseudouridine synthase 1, is essential for normal cellular processes. It produces the dyskerin protein, which has dual roles in maintaining genomic stability and facilitating protein synthesis. Dyskerin is particularly important in rapidly dividing cells, such as those in bone marrow and the gastrointestinal tract.
Dyskerin's involvement in telomere maintenance and ribosome function means that disruptions to its activity can have widespread effects on cell health and replication. Variants in DKC1 are associated with a spectrum of clinical manifestations, primarily affecting tissues with high cell turnover.
What the gene does
The dyskerin protein, encoded by the DKC1 gene, performs two primary functions within cells. Firstly, it is integral to the maintenance of telomeres, which are protective DNA-protein structures at the ends of chromosomes [PMID:17950749]. Dyskerin achieves this by binding to human telomerase RNA (hTR), a component of the telomerase enzyme complex, and helping to stabilise it. Telomerase is responsible for adding repetitive DNA sequences to telomeres, counteracting their natural shortening during cell division and preventing chromosomal damage.
Secondly, dyskerin is involved in the production of ribosomal RNA (rRNA), which is a chemical cousin of DNA. Ribosomal RNA is a crucial component of ribosomes, the cellular machinery responsible for translating genetic information into proteins. By participating in rRNA processing, dyskerin indirectly supports the fundamental process of protein synthesis, which is vital for all cellular activities [PMID:10077649].
Video: Genetics 101
Chromosome location
The DKC1 gene is located on the long (q) arm of the X chromosome at position 28, denoted as Xq28. This chromosomal location means that conditions caused by variants in DKC1 typically follow an X-linked inheritance pattern.
Protein structure
The dyskerin protein consists of 514 amino acids and features several distinct regions important for its function. An N-terminal region spanning amino acids 2-21 is identified as a Nucleolar localization signal, directing the protein to the nucleolus. A PUA domain is found between amino acids 296 and 371, which is often involved in RNA binding. The C-terminal part of the protein, from amino acids 443-514, is characterised as a Disordered region. Within this disordered region, amino acids 446-514 also contain a Nuclear and nucleolar localization signal, reinforcing its crucial localisation within the cell.
Key variants
Variants in the DKC1 gene can alter the structure or function of the dyskerin protein, leading to impaired telomere maintenance or ribosomal RNA production. More than 40 mutations in the DKC1 gene have been identified in individuals with dyskeratosis congenita [PMID:10077649]. These include missense, nonsense, and frameshift changes. The impact of these variants can range from mild to severe, depending on the specific alteration and its effect on protein activity. Due to the X-linked inheritance pattern, males are typically more severely affected than females who are carriers.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.1058C>T | p.Ala353Val | Pathogenic | ★★☆☆ | DKC1-Related Disorders |
c.146C>T | p.Thr49Met | Pathogenic | ★★☆☆ | Dyskeratosis congenita |
c.189T>G | p.Asn63Lys | Pathogenic/Likely pathogenic | ★★☆☆ | DKC1-Related Disorders |
c.196A>G | p.Thr66Ala | Pathogenic/Likely pathogenic | ★★☆☆ | Dyskeratosis congenita |
c.1156G>A | p.Ala386Thr | Pathogenic | ★☆☆☆ | Dyskeratosis congenita, X-linked |
c.1345C>G | p.Arg449Gly | Pathogenic | ★☆☆☆ | not provided |
c.16+592C>G | - | Pathogenic | ★☆☆☆ | DKC1-related disorder |
c.203A>G | p.His68Arg | Pathogenic | ★☆☆☆ | Dyskeratosis congenita, X-linked |
c.5_7del | p.Ala2del | Pathogenic | ★☆☆☆ | Dyskeratosis congenita |
c.969T>A | p.Tyr323Ter | Pathogenic | ★☆☆☆ | Dyskeratosis congenita |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Pathogenic variants in the DKC1 gene are primarily associated with Dyskeratosis congenita (X-linked), a rare inherited disorder. This condition is characterised by a classic triad of symptoms: changes in skin pigmentation, nail dystrophy (abnormally formed fingernails and toenails), and oral leukoplakia (white patches inside the mouth). Individuals with this condition have an increased risk of developing bone marrow failure, pulmonary fibrosis, and certain cancers.
Inheritance pattern
Conditions caused by pathogenic DKC1 variants typically follow X-linked inheritance.
Carrier frequency by population How common is heterozygous DKC1 carrier status across ancestry groups?UK clinical status
The DKC1 gene is recognised within the UK's National Genomic Medicine Service pathways and is included on several NHS England National Genomic Test Directory panels. It has a 'green' status on panels such as 'Ataxia and cerebellar anomalies - childhood onset', 'Cytopenia - NOT Fanconi anaemia', 'Familial pulmonary fibrosis', 'Haematological malignancies cancer susceptibility', and 'Primary immunodeficiency or monogenic inflammatory bowel disease', indicating strong evidence for its gene-disease association in these contexts.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What is the main function of the DKC1 gene?
The DKC1 gene provides instructions for making the dyskerin protein, which has two main roles: maintaining telomeres at the ends of chromosomes and facilitating the production of ribosomal RNA (rRNA) for protein synthesis.
What condition is most commonly associated with DKC1 variants?
The condition most commonly associated with pathogenic variants in the DKC1 gene is X-linked dyskeratosis congenita. This disorder affects the skin, nails, and mucous membranes, and increases the risk of other serious health issues.
How is DKC1 related to telomeres?
The dyskerin protein, encoded by DKC1, helps stabilise the telomerase enzyme complex. Telomerase is crucial for adding repetitive DNA segments to telomeres, preventing them from shortening too much during cell division and protecting the chromosomes.
References
- Ballew BJ, Savage SA. Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders. Expert review of hematology. 2013. PMID: 23782086
- Dokal I. Dyskeratosis congenita. Hematology. American Society of Hematology. Education Program. 2011. PMID: 22160078
- Rostamiani K, Klauck SM, Heiss N. Novel mutations of the DKC1 gene in individuals affected with dyskeratosis congenita. Blood cells, molecules & diseases. 2010. PMID: 19879169
- Nishio N, Kojima S. Recent progress in dyskeratosis congenita. International journal of hematology. 2010. PMID: 20882440
- Montanaro L. Dyskerin and cancer: more than telomerase. The defect in mRNA translation helps in explaining how a proliferative defect leads to cancer. The Journal of pathology. 2010. PMID: 20925138
- Gu B, Bessler M, Mason PJ. Dyskerin, telomerase and the DNA damage response. Cell cycle (Georgetown, Tex.). 2009. PMID: 19106610
- Walne AJ, Dokal I. Advances in the understanding of dyskeratosis congenita. British journal of haematology. 2009. PMID: 19208095
- Kirwan M, Dokal I. Dyskeratosis congenita, stem cells and telomeres. Biochimica et biophysica acta. 2009. PMID: 19419704
- Vulliamy TJ, Dokal I. Dyskeratosis congenita: the diverse clinical presentation of mutations in the telomerase complex. Biochimie. 2008. PMID: 17825470
- Kirwan M, Dokal I. Dyskeratosis congenita: a genetic disorder of many faces. Clinical genetics. 2008. PMID: 18005359